Equities Analysts Set Expectations for CRL Q2 Earnings

Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) – Equities research analysts at Zacks Research upped their Q2 2026 earnings per share estimates for shares of Charles River Laboratories International in a research report issued on Monday, April 7th. Zacks Research analyst R. Department now anticipates that the medical research company will post earnings […]